Die kartellrechtliche Zulässigkeit von Pay-for-Delay-Vereinbarungen in den USA und der EU.

»The Antitrust Assessment of Pay-for-Delay Settlement Agreements in the USA and the EU«This work examines settlements between pharmaceutical companies (so-called apay-for-delay agreements) in the US and the EU. It explores questions, which have arisen from the 2013 Actavis-decision by the US Supreme Court. In the EU, the EU Commission has ruled on three cases concerning such agreements. The analysis focuses on those decision as well as the General Court's Lundbeck-ruling. It shows that those decisions are in accordance with the ECJ's settled case law.